News

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...
U.S. stock futures slipped on Monday night as the market awaited clarity from President Donald Trump regarding his tariff ...
PLAINSBORO, N.J., March 24, 2025 /PRNewswire/ -- Today, Novo Nordisk announced updates to the Wegovy ® savings program, allowing all eligible cash-paying patients access to Wegovy ® (semaglutide ...
Wegovy was approved to treat obesity in June 2021, and it is available as an injection in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg of the once-weekly, single-dose pen. Its list price is $1,349, and ...
1 National University of Singapore Centre for Biomedical Ethics, Singapore 2 Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Semaglutide, ...
The US Federal Reserve announced its second monetary policy decision for 2025 after a two-day Federal Open Market Committee (FOMC) meeting and kept its benchmark interest rate steady at 4.25-4.50 ...
PCI Express 7 is nearing completion, the PCI Special Interest Group said Tuesday, and the final specification should be released later this year. PCI Express 7, the backbone of the modern ...
The latest major patch for creature collecting sandbox Palworld has been released, and Update 0.5.0 has quite a lot going on. For one, the game now has crossplay, meaning console and PC players ...
Wegovy is a prescription medication designed for chronic weight management, offering hope to individuals struggling with obesity or being overweight. Manufactured by Novo Nordisk, Wegovy contains ...
Using a random sample of 16 million patients, researchers found that women who newly initiated semaglutide (Ozempic, Wegovy) had a twofold higher risk of hair loss than those starting on the ...